Jennifer Effie Amengual

Title: Innovations and Contributions of Jennifer Effie Amengual

Introduction

Jennifer Effie Amengual is a prominent inventor based in Scarsdale, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer and neurodegenerative disorders. With a total of five patents to her name, her work has the potential to impact many lives.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Histone acetyltransferase activators and compositions and uses thereof." This invention provides pharmaceutical compositions and methods for treating cancer, neurodegenerative disorders, and conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein by administering a HAT modulator and a HDAC modulator to a subject. Another notable patent is focused on the "Combination therapy of lymphoma," which offers methods and compositions for treating cancer. In this case, a subject with lymphoma is administered an EZH2 inhibitor and an HDAC inhibitor, producing a synergistic effect on the cancer compared to the effect of either inhibitor alone.

Career Highlights

Jennifer is affiliated with Columbia University, where she continues her research and development in innovative therapies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Some of her notable coworkers include Owen Anthony O'Connor and Donald W. Landry. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Jennifer Effie Amengual's contributions to the field of pharmaceuticals through her innovative patents highlight her dedication to improving healthcare. Her work exemplifies the impact that dedicated inventors can have on society.